SCHEMBL3345123

SCHEMBL3345123

Cc1c(Cc2ccc(Cl)cc2)c(=O)[nH]c2ccc(Cl)c(O)c12

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49
KMT2A Q03164 1/20 0.49
KDM4E B2RXH2 2/20 0.43
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2A Q12879 1/20 0.42
GRIN2B Q13224 1/20 0.42
GRIN2C Q14957 1/20 0.42
GRIN3A Q8TCU5 1/20 0.42
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
SLC2A1 P11166 1/20 0.38
DAO P14920 1/20 0.37
ALOX5 P09917 2/20 0.36
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3344730 0.82 ALDH1A1 (0.46) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL3779299 0.80 DAO (0.40) ALDH1A1MEN1MAPTKMT2APTGS1
SCHEMBL3349053 0.79 ALDH1A1 (0.45) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL3351508 0.78 PTGS2 (0.37) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL3345068 0.74 CYP2C9 (0.41) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL3344884 0.73 SLC2A1 (0.39) ALDH1A1MEN1MAPTKMT2APTGS1
SCHEMBL3344758 0.72 PTGDR2 (0.51) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL3345086 0.72 ALKBH3 (0.42) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL14315177 0.72 ERAP1 (0.43) ALDH1A1MEN1MAPTKMT2AGRIN1
SCHEMBL3345122 0.71 ALDH1A1 (0.43) ALDH1A1MEN1MAPTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010040989-A1 QUINOLIN-2-ONE COMPOUNDS ARGENTA ORAL THERAPEUTICS LIMITED (GB) 2010-04-15 WO disclosed